Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bayer AG (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BAYRY
Over the counter
2834
https://www.bayer.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bayer AG (ADR)
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
- Apr 24th, 2024 1:11 pm
Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
- Apr 24th, 2024 10:50 am
How Roundup lawsuits could give China an edge
- Apr 13th, 2024 12:00 pm
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
- Apr 11th, 2024 11:13 am
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
- Apr 9th, 2024 8:13 pm
Here’s Why Bayer Aktiengesellschaft (BAYRY) Detracted in Q1
- Apr 8th, 2024 2:29 pm
Judge slashes Bayer $1.56 billion Roundup verdict to $611 million
- Apr 5th, 2024 8:56 pm
Bayer’s $1.5 Billion Roundup Verdict Slashed to $600 Million
- Apr 5th, 2024 8:28 pm
Bayer-Backed Boundless Bio Falls 11% After $100 Million IPO
- Mar 28th, 2024 8:33 pm
Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO
- Mar 27th, 2024 11:15 pm
Bayer (BAYRY) Banks on Pipeline Progress Amid Challenges
- Mar 25th, 2024 2:05 pm
Thermo Fisher (TMO) Inks Deal to Develop Companion Diagnostics
- Mar 22nd, 2024 1:41 pm
One CEO’s Radical Fix for Corporate Troubles: Purge the Bosses
- Mar 22nd, 2024 4:01 am
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding
- Mar 21st, 2024 7:00 pm
Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
- Mar 21st, 2024 1:46 pm
Bayer streamlines pharma leadership team amid company shakeup
- Mar 21st, 2024 11:00 am
Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study
- Mar 20th, 2024 6:00 pm
With new data, Bayer readies rival to Astellas menopause drug
- Mar 19th, 2024 11:58 am
Bayer CEO: Now is not the time to break the company up
- Mar 14th, 2024 9:09 pm
Inflation: Over-the-counter drug prices leap year over year
- Mar 13th, 2024 4:20 pm
Scroll